Novavax Inc

NVAX
13,09
-1,31 (-9,10%)
18 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/5/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202423:02EDGAR2Form 144 - Report of proposed sale of securities
13/5/202422:10EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
13/5/202422:02PRNUSNovavax to Participate in BofA Securities 2024 Health Care..
13/5/202420:39EDGAR2Form 8-K - Current report
10/5/202414:07EDGAR2Form 8-K - Current report
10/5/202414:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202414:02IHMARKETNEWSNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple..
10/5/202408:15PRNUSNovavax Reports First Quarter 2024 Financial Results and..
10/5/202408:00PRNUSNovavax and Sanofi Announce Co-exclusive Licensing Agreement..
08/5/202422:53EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
07/5/202423:21EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
07/5/202420:43EDGAR2Form SC 13D/A - General statement of acquisition of..
07/5/202415:25PRNUSNovavax to Host Conference Call to Discuss First Quarter..
07/5/202413:44IHMARKETNEWSTesla’s April Sales Down 18% in China, Amazon’s..
06/5/202422:43EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
06/5/202412:22GLOBEShah Capital Launches Campaign Urging Stockholders to Vote..
15/4/202412:00GLOBEShah Capital nominates two highly qualified independent..
01/4/202414:00PRNUSNovavax Presents Data on Updated COVID-19 Vaccine and..
06/3/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:02PRNUSNovavax to Participate in TD Cowen's 44th Annual Health Care..
28/2/202414:07EDGAR2Form 8-K - Current report
28/2/202414:00PRNUSNovavax Reports Fourth Quarter and Full Year 2023 Financial..
28/2/202413:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202414:03IHMARKETNEWSGoldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in..
22/2/202412:02EDGAR2Form 8-K - Current report
22/2/202412:00PRNUSNovavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine..
20/2/202415:25PRNUSNovavax to Host Conference Call to Discuss Fourth Quarter..
31/1/202414:00EDGAR2Form 8-K - Current report
25/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:25EDGAR2Form 8-K - Current report
03/1/202415:25PRNUSNovavax to Participate in the 42nd Annual J.P. Morgan..
18/12/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202314:00PRNUSNovavax's Updated COVID-19 Vaccine Receives Emergency Use..
13/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202323:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/12/202314:31DJNModerna Shares, Other Covid Vaccine Makers Hit by Warning..
13/12/202314:00PRNCACanadians Can Help Protect Loved Ones as We Head into the..
05/12/202322:01PRNCANovavax's Updated COVID-19 Vaccine Now Authorized in Canada
05/12/202314:45EDGAR2Form 8-K - Current report
28/11/202319:13IHMARKETNEWSWall Street Radar: Amazon, Blackrock, General Motors, Eli..
28/11/202312:00PRNUSNovavax's Updated Protein-based COVID-19 Vaccine Now an..
17/11/202322:36EDGAR2Form 8-K - Current report
17/11/202313:15PRNUSNovavax Makes Changes to Executive Leadership Team to..
10/11/202315:25PRNUSNovavax to Participate in Jefferies London Healthcare..
09/11/202314:05EDGAR2Form 8-K - Current report
09/11/202314:00PRNUSNovavax Reports Third Quarter 2023 Financial Results and..
09/11/202313:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 14,34 Min: 12,95 Max: 14,38
Chiusura: 14,40

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network